12 - C . O . P . D mcqs

Question 1
1. Which of the following statements is not true with regard to COPD?
A.COPD is an internationally recognized term used to indicate chronic bronchitis and emphysema.
B.Key feature of COPD is poor reversibility of airflow limitation even after giving bronchodilators.
C.COPD is more common in young age.----------------
D.COPD originates in the peripheral airways and in the air spaces of the lungs.

Question 2
2. Which of these is not a risk factor for COPD?
A. Homozygous serum alpha-1 antitrypsin deficiency.
B. Thiazide diuretics
C. Potassium sparing diuretics
D. Osmotic diuretics---------------

Question 3
3. Diagnosis of COPD can be firmly made by:
A. Spirometery---------
B. X-ray chest
C. Auscultation
D. Blood Test

Question 4
4. Which of these factors is most important in predicting survival in a patient with COPD?
A. Age
B. Pre-brochodilator FEV1
C. Post-brochodilator FEV1----------
D. Total lung capacity

Question 5
5. Which of these factors if present suggest the diagnosis COPD?
A. Long history of heavy smoking.
B. Chronic cough with large amount of sputum production.
C. Breathlessness mainly on exertion, which is gradually increasing.
D. All of the above------------------

Question 6
6. Lung function test useful in differentiating COPD from asthma:
A. FEV1 after bronchodilatation.
B. Total lung capacity
C. Diffusion of gases (DLCO)
D. All of the above---------------

Question 7
7. Advanced COPD may lead to:
A. Oedema
B. Cor pulmonale
C. Pulmonary hypertension
D. Any of the above------------------

Question 8
8. Ipratropium is a
A. Beta agonist
B. Anticholinergic---------------
C. Corticosteroid
D. Methylxanthine

Question 9
9. Theophylline benefits COPD patient in many ways. Which of these statements is not true with regard to this medication?
A. Reduces pulmonary artery pressure.
B. Increases arterial oxygen tension
C. Increases right ventricular function.
D. Inhibits central respiratory activity.------------------

Question 10
10. While evaluating therapeutic potential of any compound used for treatment of COPD, parameters that should be considered apart from FEV1 are:
A. Symptoms---------------
B. Exercise tolerance
C. Exacerbation rates
D. All of the above

Question 11
11. Potential arrythmogenic factor in COPD patient could be any of these except:
A. Acid- base disturbance
B. Hypoxaemia
C. Treatment with Theophylline
D. Treatment with Ipratopium----------------

Question 12
12. Tremor and tachycardia in a COPD patient could be a side effect of which of these drugs?
A. Salbutamol------------
B. Ipratopium
C. Theophylline
D. Budesonide

Question 13
13. Preferred route of administration of beta agonist in COPD patient is:
A. Oral-------------
B. Inhalation
C. Injectible
D. Sublingual

Question 14
14. To be beneficial, domiciliary supplementary oxygen therapy should be given for at least:
A. 3 hours/day
B. 5 hours/day
C. 10 hours/day
D. 15 hours/day--------------

Question 15
15. Predicted 3-year survival in a patient aged more than 60 years, with FEV1 40-49% is:
A. 90%
B. 75%----------
C. 50%
D. 25%